Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Rupa Narayan, M.D.

Concepts (62)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cytokine-Induced Killer Cells1201940.760 Why?
Myeloproliferative Disorders320225910.750 Why?
Leukemia, Myeloid, Acute4202232810.610 Why?
Immunoconjugates120198310.470 Why?
Myelodysplastic Syndromes2201912550.390 Why?
Tissue Donors1201921470.370 Why?
Hematologic Neoplasms1201916870.330 Why?
Antineoplastic Combined Chemotherapy Protocols22019112530.300 Why?
Hematopoietic Stem Cell Transplantation2202251350.280 Why?
Multiple Myeloma1202050440.230 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma2202214540.220 Why?
Mitoxantrone120191530.190 Why?
Philadelphia Chromosome12020980.190 Why?
Maximum Tolerated Dose220199140.190 Why?
Disease-Free Survival2201970260.170 Why?
Etoposide120196310.170 Why?
Cytarabine120196890.170 Why?
Eosinophilia120205170.150 Why?
BH3 Interacting Domain Death Agonist Protein12015960.140 Why?
Antifungal Agents120207100.140 Why?
Recurrence3202282550.130 Why?
Milk Thistle1201330.130 Why?
Azacitidine120152970.130 Why?
Silymarin12013200.130 Why?
Retreatment120156280.130 Why?
Phosphatidylcholines120134380.110 Why?
Drug Administration Schedule1201950450.100 Why?
Graft vs Host Disease1202228180.100 Why?
Thalidomide120159190.100 Why?
Aged520201614880.080 Why?
Middle Aged620202137520.070 Why?
Bone Marrow1201529380.070 Why?
Antioxidants1201316780.070 Why?
Aged, 80 and over32020581840.070 Why?
In Situ Hybridization, Fluorescence2202226680.070 Why?
Drug Resistance, Neoplasm1201951970.070 Why?
Survival Rate12019132020.060 Why?
Adult520202110410.060 Why?
Male720223495240.060 Why?
Oncogene Proteins, Fusion2202215970.060 Why?
Neoplasms22021201720.060 Why?
Carcinoma, Hepatocellular1201320600.050 Why?
Nuclear Pore Complex Proteins120221660.050 Why?
Humans1220227088430.050 Why?
Female520203752050.050 Why?
Age Factors12015187120.040 Why?
Liver Neoplasms1201340440.040 Why?
Genetic Predisposition to Disease12019172180.040 Why?
Young Adult22020559400.040 Why?
Cardiovascular Diseases12019140750.030 Why?
Retrospective Studies12020714830.030 Why?
Pyrazoles1202019540.020 Why?
Treatment Outcome12015619320.020 Why?
Pyrimidines1202029500.020 Why?
Immunotherapy1202240570.020 Why?
Incidence12020203200.010 Why?
Dose-Response Relationship, Drug12013112390.010 Why?
Prognosis12019289190.010 Why?
Risk Assessment12019232840.010 Why?
Disease Progression12013132980.010 Why?
Mutation12019292620.010 Why?
Risk Factors12019695530.010 Why?
Narayan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (62)
Explore
_
Co-Authors (32)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.